bioRxiv/medRxiv TRiP Review Activity

6,423 Reviews — eLife — All Subjects

Most recent first Previous |  Page 21: Articles 201-210  | Next

Phosphodiesterase 1A physically interacts with YTHDF2 and reinforces the progression of non-small cell lung cancer
Zhang, C., Zhang, Z., Wu, Y., Cheng, J., Luo, K., Li, Z., Zhang, M., Wang, J., Li, Y.
10.1101/2024.05.21.595220 — Posted: 2024-05-23 — Discussion: 2024-10-15  eLife
Single-nucleus transcriptomics reveal the cytological mechanism of conjugated linoleic acids in regulating intramuscular fat deposition
Wang, L., Liu, S., Zhang, S., Wang, Y., Zhou, Y., Shan, T.
10.1101/2024.05.30.596608 — Posted: 2024-05-30 — Discussion: 2024-10-15  eLife
One N-glycan regulates natural killer cell antibody-dependent cell-mediated cytotoxicity and modulates Fc γ receptor IIIa / CD16a structure
Kremer, P. G., Lampros, E. A., Blocker, A. M., Barb, A. W.
10.1101/2024.06.17.599285 — Posted: 2024-06-18 — Discussion: 2024-10-15  eLife
Protein-Induced Membrane Strain Drives Supercomplex Formation
Poverlein, M. C., Jussupow, A., Kim, H., Kaila, V. R. I.
10.1101/2024.07.13.602826 — Posted: 2024-07-17 — Discussion: 2024-10-15  eLife
Amidase and Lysozyme Dual Functions in TseP Reveal a New Family of Chimeric Effectors in the Type VI Secretion System
Wang, Z.-H., An, Y., Zhao, T., Pei, T.-T., Wang, D. Y., Liang, X., Qin, W., Dong, T.
10.1101/2024.07.24.605002 — Posted: 2024-07-26 — Discussion: 2024-10-15  eLife
Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanism
Wu, W., Yu, M., Li, Q., Zhao, Y., Zhang, L., Sun, Y., Wang, Z., Gong, Y., Wang, W., Liu, C., Zhang, J., Tang, Y., Xu, X., Guo, X., Zhan, J., Zhang, H.
10.1101/2024.08.01.606147 — Posted: 2024-08-04 — Discussion: 2024-10-15  eLife
Plectin-mediated cytoskeletal crosstalk as a target for inhibition of hepatocellular carcinoma growth and metastasis.
Korelova, K., Prechova, M., Frick, L., Sarnova, L., Bisht, P., Novotna, P., Kosla, J., Bortel, P., Borutzki, Y., Bileck, A., Gerner, C., Rahbari, M., Rahbari, N., Birgin, E., Kvasnicova, B., Galisova, A., Sulkova, K., Bauer, A., Jobe, N., Tolde, O., Sticova, E., Rosel, D., O Connor, T., Otahal, M., Jirak, D., Heikenwalder, M., Wiche, G., Meier-Menches, S. M., Gregor, M.
10.1101/2024.08.02.606331 — Posted: 2024-08-06 — Discussion: 2024-10-15  eLife
LAPTM4B Alleviates Pulmonary Fibrosis by Enhancing NEDD4L-Mediated TGF-beta Signaling Suppression
Xu, K., Pan, X., Lian, H., Wang, Y., Wan, R., Li, Z., Pan, X., Li, Y., Yang, J., Rosas, I., Wang, L., Yu, G.
10.1101/2024.08.30.610429 — Posted: 2024-08-30 — Discussion: 2024-10-15  eLife
Crystal structure and catalytic mechanism of PL35 family glycosaminoglycan lyases with an ultrabroad substrate spectrum
Wei, L., Cao, H.-Y., Zou, R., Du, M., Zhang, Q., Lu, D., Xu, X., Xu, Y., Wang, W., Chen, X.-L., Zhang, Y.-Z., Li, F.
10.1101/2024.09.04.611182 — Posted: 2024-09-04 — Discussion: 2024-10-15  eLife
Limited evidence of tumour mutational burden as a biomarker of response to immunotherapy
Gurjao, C., Tsukrov, D., Imakaev, M., Luquette, L. J., Mirny, L. A.
10.1101/2020.09.03.260265 — Posted: 2020-09-04 — Discussion: 2024-10-14  eLife

Evaluation Sources